BSG and urinary bladder cancer: Without heterogeneity (P=0.88, I2=0%), the fixed-effects model showed that CD147 expression was higher in bladder cancer tissues (OR=43.64, 95% CI=[23.26, 81.87], P<0.00001) (Figure 3A).